Clinical Studies
Please if you are interested in learning more about our ongoing clinical studies or check .
ATA3219
- Phase
- Trial Number
- Trial Description
- 1
- Phase 1 Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Subjects With Relapsed/Refractory B-cell Non-Hodgkin鈥檚 Lymphoma
- 1
- Phase l Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Subjects With Lupus Nephritis
Enrollment
For more information on enrollment in our current clinical trials, please contact us or visit clinicaltrials.gov for location information.
The safety and efficacy of these investigational products have not been established. There is no guarantee that the investigational use listed will be filed with and/or approved for marketing by a regulatory agency.